Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1984-11-28
pubmed:abstractText
In male rats, anaesthetized with pentobarbitone, ligation of the main left coronary artery causes an early phase of ventricular arrhythmias which last about 30 min. In approximately 60% of control animals, ventricular fibrillation occurs but since spontaneous reversion to sinus rhythm may occur, mortality is of the order of 30%. When administered intravenously 15 min prior to ligation, verapamil (0.01 and 0.05 mg kg-1), prenylamine (0.5 mg kg-1), flunarizine (0.1, 0.25, 0.5 and 1.0 mg kg-1) and cinnarizine (0.25, 0.5 and 1.0 mg kg-1) protected against these arrhythmias. Higher doses of verapamil (0.1 and 0.5 mg kg-1), prenylamine (5 mg kg-1) and flunarizine (2.5 mg kg-1) did not afford a similar protection and mortality was increased to or above control values. Death was due in prenylamine-treated rats to atrioventricular block leading to asystole whereas in those administered verapamil or flunarizine it was a consequence of persistent ventricular fibrillation. Prior to ligation, a sustained fall in mean arterial blood pressure was observed only following the administration of the highest doses of prenylamine, flunarizine and cinnarizine. Heart rate was reduced by administration of only the highest dose of prenylamine. These studies show that although the four calcium antagonists studied, i.e. verapamil, prenylamine, flunarizine and cinnarizine do suppress ischaemia-induced arrhythmias, this protective effect may be limited to a narrow concentration range.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-1178071, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-1182734, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-4746630, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-5699094, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-6876861, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-7060626, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-7388861, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-7392665, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-7411649, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-7463348, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-758229, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-837018, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-848439, http://linkedlifedata.com/resource/pubmed/commentcorrection/6487894-991164
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
299-304
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats.
pubmed:publicationType
Journal Article, Comparative Study